Announcements Trials
Browse Landscape

Phase

Phase 2 120Phase 3 53Phase 1/2 28Phase 1 25Phase 2/3 5Phase 4 3Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia 3Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Respiratory Tract Diseases 1Rare Diseases 1Prostatic Neoplasms 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hormone Refractory Prostate Cancer 1Hemangioma 1Esophageal Stenosis Acquired 1Dendritic Cell Sarcoma, Interdigitating 1COVID-19 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Radiosurgery 45Magnetic Resonance Spectroscopy 41Standard of Care 27Radiotherapy 27Exercise 27Brachytherapy 21Early Intervention, Educational 20Surveys and Questionnaires 18Multiparametric Magnetic Resonance Imaging 17Magnetic Resonance Imaging 16Androgen Antagonists 16Blood Specimen Collection 15Interviews as Topic 14Radiotherapy, Intensity-Modulated 13Methods 13Therapeutics 12Psychiatric Rehabilitation 12Educational Status 12Biopsy 12Specimen Handling 10Resistance Training 10Prostatectomy 9Diet Therapy 9Counseling 9gallium 68 PSMA-11 8Radiation 8Proton Therapy 8Practice Guidelines as Topic 8High-Intensity Interval Training 7Electroporation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostatic Neoplasms × Prednisone × Clear all
NCT01961843 2025-11-25

Abiraterone Acetate for Castrate Resistant Prostate Cancer

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡